Previously some thaizole and triazole derivatives shown in Figure 1 have been reported as tyrosinase inhibitors (48-53), so the present investigation was rationalized to explore the therapeutic potential of new thiazole-triazole hybrid molecules as tyrosinase inhibitors to overwhelm the problems of skin disorders. The gene discussed is TYR; the disease is skin disorder.